We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
GEHC icon
51
GE HealthCare
GEHC
$31.7B
$31.7B $70.26 0.76%
CNC icon
52
Centene
CNC
$31.7B
$31.7B $64.07 0.49%
BIIB icon
53
Biogen
BIIB
$30.8B
$30.8B $208.45 3.29%
ILMN icon
54
Illumina
ILMN
$30.7B
$30.7B $203.01 2.45%
ALNY icon
55
Alnylam Pharmaceuticals
ALNY
$29.3B
$29.3B $219 0.6%
MTD icon
56
Mettler-Toledo International
MTD
$28.8B
$28.8B $1,437 0.55%
PHG icon
57
Philips
PHG
$25.9B
$25.9B $26.47 0.91%
DGX icon
58
Quest Diagnostics
DGX
$25.8B
$25.8B $233.72 0.76%
RPRX icon
59
Royalty Pharma
RPRX
$25.5B
$25.5B $57.48 0.54%
LH icon
60
Labcorp
LH
$25.3B
$25.3B $312.34 1.6%
ROIV icon
61
Roivant Sciences
ROIV
$25B
$25B $34.59 3.81%
WST icon
62
West Pharmaceutical
WST
$24.5B
$24.5B $348.76 0.24%
INCY icon
63
Incyte
INCY
$24.4B
$24.4B $120.60 1.83%
BNTX icon
64
BioNTech
BNTX
$23.1B
$23.1B $91.35 0.98%
MRNA icon
65
Moderna
MRNA
$22.8B
$22.8B $56.99 3.36%
STE icon
66
Steris
STE
$22.7B
$22.7B $232.85 0.09%
UTHR icon
67
United Therapeutics
UTHR
$22B
$22B $518.77 0.48%
GH icon
68
Guardant Health
GH
$21.4B
$21.4B $159.79 0.6%
INSM icon
69
Insmed
INSM
$21.4B
$21.4B $98.75 0.3%
VTRS icon
70
Viatris
VTRS
$20.6B
$20.6B $17.70 0.4%
THC icon
71
Tenet Healthcare
THC
$20.4B
$20.4B $253.33 1.34%
ZBH icon
72
Zimmer Biomet
ZBH
$18.5B
$18.5B $95.81 1.21%
GMAB icon
73
Genmab
GMAB
$17.8B
$17.8B $29.02 1.19%
NBIX icon
74
Neurocrine Biosciences
NBIX
$16.9B
$16.9B $166.06 0.1%
JAZZ icon
75
Jazz Pharmaceuticals
JAZZ
$16.4B
$16.4B $261.62 3.99%
1 2
3
4 5

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.94T.

The largest by market cap are Eli Lilly (LLY) at $995B, Johnson & Johnson (JNJ) at $614B and AbbVie (ABBV) at $431B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $8.94T across 1,066 stocks.
  • Largest constituent: Eli Lilly (LLY), $995B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.